Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Journal of Clinical Medicine
|
December 23, 2023
Resection of a Solitary Right Ventricular Metastasis in Oligorecurrent Hepatocellular Carcinoma
Defne Gunes Ergi, Kyle W Klarich, Joseph A Dearani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2003
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer
James A Martenson, Antonio P G Vigliotti, Henry C Pitot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741
Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841
George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer
Elisabeth I Heath, David W Hillman, Ulka Vaishampayan, et al.
Cancer
|
November 2, 2004
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma
Evanthia Galanis, Patrick A Burch, Ronald L Richardson, et al.
Carcinogenesis
|
June 13, 2009
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice
Alicia G Cleveland, Seija I Oikarinen, Kimberly K Bynoté, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 20, 2021
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer
Caleb J Smith, Tanios S Bekaii-Saab, Kathryn D Cook, et al.
Cancer Research
|
July 9, 2009
Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway
Richard B Halberg, Jesse Waggoner, Kristen Rasmussen, et al.
American Journal of Clinical Oncology
|
August 8, 2006
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization
Svetomir N Markovic, Vera J Suman, James N Ingle, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Journal of Clinical Medicine
|
December 23, 2023
Resection of a Solitary Right Ventricular Metastasis in Oligorecurrent Hepatocellular Carcinoma
Defne Gunes Ergi, Kyle W Klarich, Joseph A Dearani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 26, 2003
A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer
James A Martenson, Antonio P G Vigliotti, Henry C Pitot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741
Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2009
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841
George P Kim, Daniel J Sargent, Michelle R Mahoney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer
Elisabeth I Heath, David W Hillman, Ulka Vaishampayan, et al.
Cancer
|
November 2, 2004
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma
Evanthia Galanis, Patrick A Burch, Ronald L Richardson, et al.
Carcinogenesis
|
June 13, 2009
Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/+) mice
Alicia G Cleveland, Seija I Oikarinen, Kimberly K Bynoté, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 20, 2021
Nanoliposomal irinotecan (Nal-IRI)-based chemotherapy after irinotecan -based chemotherapy in patients with pancreas cancer
Caleb J Smith, Tanios S Bekaii-Saab, Kathryn D Cook, et al.
Cancer Research
|
July 9, 2009
Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway
Richard B Halberg, Jesse Waggoner, Kristen Rasmussen, et al.
American Journal of Clinical Oncology
|
August 8, 2006
Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization
Svetomir N Markovic, Vera J Suman, James N Ingle, et al.
Page
of 9